Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$365,157
+$11,541 QoQ
Shares Held
2,330
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,031
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koshinski Asset Management, Inc. holds $47,150,309 across 10 Drug Manufacturers - General names. NVS ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,147 | $21,370,813 | |
| 2 | ABBV |
AbbVie Inc.
|
34,655 | $8,720,584 | |
| 3 | LLY |
ELI LILLY & Co
|
5,099 | $6,115,894 | |
| 4 | PFE |
Pfizer Inc
|
146,261 | $3,521,964 | |
| 5 | AMGN |
Amgen Inc
|
9,577 | $3,468,023 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,669 | $1,248,567 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,983 | $1,008,572 | |
| 8 | AZN |
Astrazeneca PLC
|
4,741 | $898,988 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,157 | 2,330 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $353,616 | 2,315 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $288,837 | 2,095 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $265,456 | 2,070 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $237,905 | 1,966 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $238,232 | 2,137 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $207,951 | 2,137 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $230,730 | 2,006 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $225,162 | 2,115 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $201,198 | 2,080 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $255,655 | 2,532 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $213,600 | 2,097 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $211,608 | 2,097 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $260,820 | 2,835 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $272,522 | 3,004 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $225,825 | 2,971 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $314,028 | 3,715 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $361,442 | 4,119 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $352,853 | 4,034 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $326,629 | 3,994 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $256,566 | 2,812 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $326,362 | 3,818 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $305,575 | 3,236 | Shares | Sole | 2021-03-30 | |
| 2020-09-30 | $286,446 | 3,294 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $286,824 | 3,284 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $266,808 | 3,236 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||